These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37305031)

  • 1. Diagnostic value of serum cathepsin S in type 2 diabetic kidney disease.
    Ren X; Wang W; Cao H; Shao F
    Front Endocrinol (Lausanne); 2023; 14():1180338. PubMed ID: 37305031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of triglyceride and cystatin C ratio in diabetic kidney disease: a retrospective and prospective cohort study based on renal biopsy.
    Wei J; Wang B; Shen FJ; Zhang TT; Duan Z; Zhou DM
    BMC Nephrol; 2022 Jul; 23(1):270. PubMed ID: 35896961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease.
    Xu X; Dong Y; Liu M; Li Y; Zhang Y
    Nefrologia (Engl Ed); 2021; 41(5):548-555. PubMed ID: 36165137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Human Epididymis Protein 4 is Associated with Renal Function and Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus.
    Zhang M; Zhao B; Xie J; Liang Y; Yang Z
    Biomed Res Int; 2019; 2019():4831459. PubMed ID: 31815140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and internal validation of machine learning algorithms for end-stage renal disease risk prediction model of people with type 2 diabetes mellitus and diabetic kidney disease.
    Zou Y; Zhao L; Zhang J; Wang Y; Wu Y; Ren H; Wang T; Zhang R; Wang J; Zhao Y; Qin C; Xu H; Li L; Chai Z; Cooper ME; Tong N; Liu F
    Ren Fail; 2022 Dec; 44(1):562-570. PubMed ID: 35373711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12(S)-hydroxyeicosatetraenoic acid is significantly increased in diabetic kidney disease and associated with renal function decline.
    Xu J; Jin L; Sun Y; Zhang R; Chen X; Zhou R; Gu Y; Hu C
    Diabetes Metab Res Rev; 2022 Sep; 38(6):e3554. PubMed ID: 35667014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease.
    Duan S; Chen J; Wu L; Nie G; Sun L; Zhang C; Huang Z; Xing C; Zhang B; Yuan Y
    J Diabetes Complications; 2020 Oct; 34(10):107665. PubMed ID: 32653382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of Noninvasive Detection of Advanced Glycation End Products in the Lens to Screen for Diabetic Kidney Disease.
    Zhang XM; Gao Y; Yang MX; Zheng XD; Zhang R; Wu YY; Zeng M; Yang Q; Yu ZY; Liu J; Zha BB; Yang B
    Front Endocrinol (Lausanne); 2022; 13():892070. PubMed ID: 35846309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular status of thrombospondin-2 in type 2 diabetes mellitus and utility as a biomarker in the determination of early diabetic kidney disease.
    Lin Z; Zhang D; Zhang X; Guo W; Wang W; Zhang Y; Liu Z; Bi Y; Wu M; Lin Z; Lu X
    BMC Nephrol; 2023 May; 24(1):154. PubMed ID: 37259071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Cystatin C Trajectory Is a Marker Associated With Diabetic Kidney Disease.
    Wang N; Lu Z; Zhang W; Bai Y; Pei D; Li L
    Front Endocrinol (Lausanne); 2022; 13():824279. PubMed ID: 35634510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum lutein is a promising biomarker for type 2 diabetes mellitus and diabetic kidney disease in the elderly.
    Pan F; Cui W; Gao L; Shi X; Yang H; Hu Y; Li M
    J Clin Lab Anal; 2022 Apr; 36(4):e24350. PubMed ID: 35293029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood Lipid Indicators and Different Clinical Classifications of Dyslipidemia and Diabetic Kidney Disease: Correlation and Predictive Value].
    Hu Y; Du X
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Sep; 54(5):1013-1018. PubMed ID: 37866961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease.
    Zheng X; Gao Y; Huang Y; Dong R; Yang M; Zhang X; Zeng M; Zhang R; Wu Y; Yu Z; Liu J; Zha B
    BMC Nephrol; 2023 Dec; 24(1):379. PubMed ID: 38115082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
    Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum high mobility group box 1 as a potential biomarker for the progression of kidney disease in patients with type 2 diabetes.
    Liu T; Zhao H; Wang Y; Qu P; Wang Y; Wu X; Zhao T; Yang L; Mao H; Peng L; Zhan Y; Li P
    Front Immunol; 2024; 15():1334109. PubMed ID: 38481996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study.
    Li X; Wang L; Liu M; Zhou H; Xu H
    Front Endocrinol (Lausanne); 2023; 14():1285509. PubMed ID: 38239986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of systemic immune-inflammation index with diabetic kidney disease in patients with type 2 diabetes: a cross-sectional study in Chinese population.
    Yan P; Yang Y; Zhang X; Zhang Y; Li J; Wu Z; Dan X; Wu X; Chen X; Li S; Xu Y; Wan Q
    Front Endocrinol (Lausanne); 2023; 14():1307692. PubMed ID: 38239983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.